The approach for the Plastid Company is to produce great quantities of plastids or mini cells in the plants. There are millions of these cells in each plant and they will function as efficient bio factories. The proteins will be used by research laboratories, the health service, the feed and fish industries and the pharmaceutical industry.
In addition to standard proteins Plastid will also design and produce new proteins and enzymes in demand by the market.
The production of proteins in plastids has until now been difficult, partly because it is a complicated process to put a gene into a plastid and then make a plant grow from this single plant cell.
By applying our procedures we get the right plant after two to three months. The aim is to shorten the process to one to two months. When we have the plant which produces the protein demanded by the customer, we can simply expand – we will just grow more plants. Møller says.
The Plastid Company can develop products adapted to all illnesses caused by defective proteins. A particularly interesting area is the so-called kinases, proteins which are active in transmission of signals in our body. Defect kinases cause around 400 different serious illnesses from cancer to neurological ailments.
One example is stomach cancer where a special kinase is always switched on. Stomach cancer patients therefore need inhibitors of this kinase. They must be developed continuously since our patients become resistant to inhibitors after a while, Møller explains.
We want to produce kinases in our system which may be used for developing new inhibitors for these patients. We have already managed to produce a kinase, even though this is a process in which success is not easily achieved. It shows that we are able to manage this within our patented system. There is a large market for new proteins in the industry, but the infrastructure has so far been expensive. Plastid's system is robust and the production can easily be increased or reduced, Møller says.
Silje Stangeland | alfa
Closing the carbon loop
08.12.2016 | University of Pittsburgh
Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences